AIxCrypto Holdings is an early-stage company developing two platforms: real-world asset (RWA) tokenization infrastructure and Embodied AI (EAI) infrastructure. AIxCrypto was formerly Qualigen Therapeutics, a pharmaceutical company, and rebranded in late 2025 following a $41M PIPE financing led by Faraday Future, an electric vehicle company. AIxCrypto has 10 employees, no commercial revenue, and carries a going concern qualification from its auditors. On the RWA side, AIxCrypto is building software that puts traditional assets onto blockchain networks with compliance logic embedded in smart contracts. On the EAI side, AIxCrypto is developing the AIxC Hub, a platform intended to facilitate the registration and deployment of AI models for physical systems like autonomous vehicles and robotics. The AIxC Hub has surpassed 1 million registered wallets, but currently operates on a zero-fee model, so wallet registrations do not generate revenue. AIxCrypto's intended revenue model includes platform licensing fees, asset structuring and transaction fees, and ecosystem participation fees from the AIxC Hub. Faraday Future is both the lead PIPE investor and the primary intended commercial partner for the EAI platform, though no definitive commercial agreements have been signed. AIxCrypto also retains a legacy drug development program from its prior life as Qualigen Therapeutics and is evaluating whether to continue, license, or sell that asset.